Clinical Trial Update: Cephea Early Feasibility Study [NA]

View source ↗

Summary

Abbott Medical Devices is conducting the Cephea Early Feasibility Study for mitral regurgitation, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Drugs mentioned

• Cephea Transcatheter Mitral Valve System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Mitral Regurgitation | NA | Status: RECRUITING